Health-related quality-of-life measurement in hypertension. A review of randomised controlled drug trials

PharmacoEconomics
I CôtéJ Moisan

Abstract

In hypertension, tolerability of drug treatment is important because individuals may see the use of antihypertensive medications as more troubling than their seemingly symptomless disease. This may result in noncompliance and ineffectual long term treatment. In the past 15 years, new antihypertensive medications have been marketed on the basis of the advantages they offer with regard to adverse effects and the unavoidable impact of such adverse effects on a person's quality of life. When related to health, quality of life refers to the physical, psychological and social dimensions of health that are influenced by a person's experiences, beliefs, expectations and perceptions. To measure this concept, many instruments, either generic or specific, may be used. The purpose of this study is to describe, by way of a critical review of the literature, the instruments that are most often used in the measurement of health-related quality of life (HR-QOL) in people using antihypertensive drug treatments. We carried out a search of the literature published in English in the period January 1966 to July 2000, looking for randomised controlled trials of antihypertensive drugs. Using the Medline database, we included 77 papers in our review. ...Continue Reading

References

Jan 1, 1991·European Journal of Clinical Pharmacology·A E FletcherC J Bulpitt
Dec 1, 1991·Archives of Internal Medicine·S W ChangS B Hulley
Sep 1, 1990·British Journal of Clinical Pharmacology·A PalmerC Bulpitt
Oct 1, 1990·Clinical Pharmacology and Therapeutics·J A BlumenthalC F Emery
Jan 1, 1988·Journal of Cardiovascular Pharmacology·P K ZachariahP Zager
Jan 1, 1989·Journal of Clinical Epidemiology·D G Froberg, R L Kane
Jan 1, 1987·Clinical and Experimental Hypertension. Part A, Theory and Practice·G ChatellierJ Ménard
Apr 1, 1988·Clinical Pharmacology and Therapeutics·J A BlumenthalJ Simon
Dec 1, 1987·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·S KazdaJ P Stasch
Jun 26, 1986·The New England Journal of Medicine·S H CroogG H Williams
Aug 1, 1995·Journal of General Internal Medicine·E J Pérez-StableD Feigal
Sep 1, 1995·Patient Education and Counseling·A J Chwalow
May 1, 1995·American Journal of Hypertension·J H LevineM Lefkowitz
Apr 1, 1994·American Journal of Hypertension·S H CroogW D Hall
Jan 1, 1994·The American Journal of Medicine·H M PerryM Sirgo
Feb 1, 1996·The New England Journal of Medicine·R J BarstUNKNOWN Primary Pulmonary Hypertension Study Group
Mar 28, 1996·The New England Journal of Medicine·M A Testa, D C Simonson
Dec 1, 1996·The American Journal of Clinical Nutrition·D C HattonD A McCarron

❮ Previous
Next ❯

Citations

Nov 6, 2004·Breast Cancer Research and Treatment·Roldano FossatiGiovanni Apolone
Feb 13, 2003·Clinical Therapeutics·Xavier BadiaUNKNOWN MINICHAL Group
Nov 15, 2011·BMJ : British Medical Journal·Michael Von KorffCarolyn M Rutter
Aug 28, 2009·Clinical Cardiology·Yan GongUNKNOWN INVEST Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.